137 related articles for article (PubMed ID: 36964293)
1. Cognitive function is mediated by deficit accumulation in older, long-term breast cancer survivors.
Ahles TA; Schofield E; Li Y; Ryan E; Orlow I; Patel SK; Traina T; Root JC
J Cancer Surviv; 2023 Mar; ():. PubMed ID: 36964293
[TBL] [Abstract][Full Text] [Related]
2. The impact of APOE and smoking history on cognitive function in older, long-term breast cancer survivors.
Ahles TA; Orlow I; Schofield E; Li Y; Ryan E; Root JC; Patel SK; McNeal K; Gaynor A; Tan H; Katheria V; Vazquez J; Corrales-Guerrero S; Sadeghi K; Traina T; Hurria A
J Cancer Surviv; 2024 Apr; 18(2):575-585. PubMed ID: 36279076
[TBL] [Abstract][Full Text] [Related]
3. Relationship between cognitive functioning and frailty in older breast cancer survivors.
Ahles TA; Schofield E; Li Y; Ryan E; Root JC; Patel SK; McNeal K; Gaynor A; Tan H; Katheria V; Vazquez J; Traina T; Hurria A
J Geriatr Oncol; 2022 Jan; 13(1):27-32. PubMed ID: 34366276
[TBL] [Abstract][Full Text] [Related]
4. Cognitive Aging in Older Breast Cancer Survivors.
Root JC; Li Y; Schofield E; Orlow I; Ryan E; Traina T; Patel SK; Ahles TA
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370818
[TBL] [Abstract][Full Text] [Related]
5. Cancer-Related Cognitive Outcomes Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study.
Mandelblatt JS; Small BJ; Luta G; Hurria A; Jim H; McDonald BC; Graham D; Zhou X; Clapp J; Zhai W; Breen E; Carroll JE; Denduluri N; Dilawari A; Extermann M; Isaacs C; Jacobsen PB; Kobayashi LC; Holohan Nudelman K; Root J; Stern RA; Tometich D; Turner R; VanMeter JW; Saykin AJ; Ahles T
J Clin Oncol; 2018 Oct; 36(32):JCO1800140. PubMed ID: 30281396
[TBL] [Abstract][Full Text] [Related]
6. Deficit Accumulation Frailty Trajectories of Older Breast Cancer Survivors and Non-Cancer Controls: The Thinking and Living With Cancer Study.
Mandelblatt JS; Zhou X; Small BJ; Ahn J; Zhai W; Ahles T; Extermann M; Graham D; Jacobsen PB; Jim H; McDonald BC; Patel SJ; Root JC; Saykin AJ; Cohen HJ; Carroll JE
J Natl Cancer Inst; 2021 Aug; 113(8):1053-1064. PubMed ID: 33484565
[TBL] [Abstract][Full Text] [Related]
7. Cognitive function prior to systemic therapy and subsequent well-being in older breast cancer survivors: Longitudinal findings from the Thinking and Living with Cancer Study.
Kobayashi LC; Cohen HJ; Zhai W; Zhou X; Small BJ; Luta G; Hurria A; Carroll J; Tometich D; McDonald BC; Graham D; Jim HSL; Jacobsen P; Root JC; Saykin AJ; Ahles TA; Mandelblatt J
Psychooncology; 2020 Jun; 29(6):1051-1059. PubMed ID: 32154959
[TBL] [Abstract][Full Text] [Related]
8. Non-pharmacological interventions for cognitive impairment due to systemic cancer treatment.
Treanor CJ; McMenamin UC; O'Neill RF; Cardwell CR; Clarke MJ; Cantwell M; Donnelly M
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011325. PubMed ID: 27529826
[TBL] [Abstract][Full Text] [Related]
9. Sleep disturbance and neurocognitive outcomes in older patients with breast cancer: Interaction with genotype.
Carroll JE; Small BJ; Tometich DB; Zhai W; Zhou X; Luta G; Ahles TA; Saykin AJ; Nudelman KNH; Clapp JD; Jim HS; Jacobsen PB; Hurria A; Graham D; McDonald BC; Denduluri N; Extermann M; Isaacs C; Dilawari AA; Root J; Stern RA; Mandelblatt JS;
Cancer; 2019 Dec; 125(24):4516-4524. PubMed ID: 31553501
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of interleukin-6 mediate neurocognitive performance in older breast cancer survivors: The Thinking and Living With Cancer study.
Mandelblatt JS; Small BJ; Zhou X; Nakamura ZM; Cohen HJ; Ahles TA; Ahn J; Bethea TN; Extermann M; Graham D; Isaacs C; Jacobsen PB; Jim HSL; McDonald BC; Patel SK; Rentscher KE; Root JC; Saykin AJ; Tometich DB; Van Dyk K; Zhai W; Breen EC; Carroll JE
Cancer; 2023 Aug; 129(15):2409-2421. PubMed ID: 37096888
[TBL] [Abstract][Full Text] [Related]
11. Cognitive features 10 or more years after successful breast cancer survival: comparisons across types of cancer interventions.
Nguyen CM; Yamada TH; Beglinger LJ; Cavanaugh JE; Denburg NL; Schultz SK
Psychooncology; 2013 Apr; 22(4):862-8. PubMed ID: 22585465
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy.
Jim HS; Phillips KM; Chait S; Faul LA; Popa MA; Lee YH; Hussin MG; Jacobsen PB; Small BJ
J Clin Oncol; 2012 Oct; 30(29):3578-87. PubMed ID: 22927526
[TBL] [Abstract][Full Text] [Related]
13. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.
Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Gundy C; Schagen SB
J Clin Oncol; 2012 Apr; 30(10):1080-6. PubMed ID: 22370315
[TBL] [Abstract][Full Text] [Related]
14. The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy.
Ahles TA; Saykin AJ; Noll WW; Furstenberg CT; Guerin S; Cole B; Mott LA
Psychooncology; 2003 Sep; 12(6):612-9. PubMed ID: 12923801
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: the impact of APOE and smoking.
Ahles TA; Li Y; McDonald BC; Schwartz GN; Kaufman PA; Tsongalis GJ; Moore JH; Saykin AJ
Psychooncology; 2014 Dec; 23(12):1382-90. PubMed ID: 24789331
[TBL] [Abstract][Full Text] [Related]
16. Age-related health deficits and five-year mortality among older, long-term cancer survivors.
Leach CR; Gapstur SM; Cella D; Deubler E; Teras LR
J Geriatr Oncol; 2022 Sep; 13(7):1023-1030. PubMed ID: 35660092
[TBL] [Abstract][Full Text] [Related]
17. Personality, coping, and social support as predictors of long-term quality-of-life trajectories in older breast cancer survivors: CALGB protocol 369901 (Alliance).
Durá-Ferrandis E; Mandelblatt JS; Clapp J; Luta G; Faul L; Kimmick G; Cohen HJ; Yung RL; Hurria A
Psychooncology; 2017 Nov; 26(11):1914-1921. PubMed ID: 28219113
[TBL] [Abstract][Full Text] [Related]
18. Advanced cognitive training for breast cancer survivors: a randomized controlled trial.
Von Ah D; Carpenter JS; Saykin A; Monahan P; Wu J; Yu M; Rebok G; Ball K; Schneider B; Weaver M; Tallman E; Unverzagt F
Breast Cancer Res Treat; 2012 Oct; 135(3):799-809. PubMed ID: 22918524
[TBL] [Abstract][Full Text] [Related]
19. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.
Ahles TA; Saykin AJ; Furstenberg CT; Cole B; Mott LA; Skalla K; Whedon MB; Bivens S; Mitchell T; Greenberg ER; Silberfarb PM
J Clin Oncol; 2002 Jan; 20(2):485-93. PubMed ID: 11786578
[TBL] [Abstract][Full Text] [Related]
20. Speed of processing training in middle-aged and older breast cancer survivors (SOAR): results of a randomized controlled pilot.
Meneses K; Benz R; Bail JR; Vo JB; Triebel K; Fazeli P; Frank J; Vance DE
Breast Cancer Res Treat; 2018 Feb; 168(1):259-267. PubMed ID: 29128897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
